 CHARLOTTESVILLE, Va., May 17, 2022 GLOBE NEWSWIRE -- Diffusion Pharmaceuticals Inc. NASDAQ: DFFN Diffusion or the Company, a biopharmaceutical company developing novel therapies that enhance the bodys ability to deliver oxygen to areas where it is needed most, today announced that Robert Cobuzzi, Jr., Ph.D., the Companys President and Chief Executive Officer, will be presenting at the H.C. Wainwright Global Investment Conference being held at the Fontainebleau Miami Beach Hotel from May 23-26, 2022. 